Megavoltage cone-beam computed tomography (CT) dose-integrated intensity modulated radiation therapy (IMRT) for visualization of soft tissue

Megavoltage cone-beam computed tomography (CT) dose-integrated intensity modulated radiation therapy (IMRT) for visualization of soft tissue - Megavoltage cone-beam CT dose-integrated IMRT for visualization of soft tissue

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004106

Enrollment

200

Registered

2010-08-27

Start date

2010-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant neoplasms that can be treated with IMRT, including locally advanced prostate, head and neck, or gynecologic cancers

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pathologically proven malignant neoplasms that can be treated with IMRT, including locally advanced prostate, head and neck, or gynecologic cancers. Age;20> informed consent

Exclusion criteria

Exclusion criteria: Age;20< Patients whose participation in the trial is judged to be inappropriate by the attendeing doctor

Design outcomes

Primary

Measure	Time frame
To calculate systematic and random error between images of treatment planning CT and cone-beam CT.	—

Countries

Japan

Contacts

Public ContactShoichi Fukuda

Osaka University Hospital Dept. of radiation oncology

Outcome results